logo-loader
RNS
viewFeedback PLC

Feedback PLC - Grant of Options

RNS Number : 7179K
Feedback PLC
24 April 2020
 

Feedback plc

Grant of Options

London, UK, 24 April 2020 - Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that it has granted a total of 19,000,000 options to subscribe for new ordinary shares in the Company under the Company's EMI Share Option Scheme ("Employee Options") to certain of its directors and employees, as detailed below.

The Employee Options are being issued in lieu of salary increases and bonuses this year, to support staff retention and to further align overall reward with increasing shareholder value.

The Employee Options are exercisable at a price of 1.2 pence per share and will vest, subject to the grantees' continued employment with the Company, over three years as to one-third on the first anniversary of the date of grant, one-third on the second anniversary of date of grant and one-third on the third anniversary of date of grant. The Employee Options expire 10 years after date of grant. The aggregate 19,000,000 Employee Options represent 3.52% of the Company's issued share capital.

The Employee Options are being granted to the following directors and persons discharging managerial responsibilities ("PDMRs"):

-     Rory Shaw, Non-executive Chairman and Chief Medical Officer of the Company, has been granted 5,000,000 Employee Options;

-     Lindsay Melvin, Finance Director of the Company, has been granted 1,500,000 Employee Options; and

-     Mike Hayball, Stephen Brown, Nick Mayhew and Stephen McAteer have each been granted 2,000,000 Employee Options.

Following the grant of the Employee Options, the Company has a total of 60,330,829 options to subscribe for ordinary shares in the Company in issue, representing 11.17% of the Company's issued share capital at the date of this announcement.

The exercise price of 1.2 pence per share reflects the price at which the Company last completed an equity fundraise in August 2019 and represents a premium of 17.65 per cent to the closing share price on the last trading day before this announcement. The Company's 30 day average closing mid-price is 0.62 pence per share and the closing share price on the last trading day before this announcement was 1.02 pence per share.

The FCA notifications, made in accordance with the requirements of the EU Market Abuse Regulation, are appended below.

Enquiries:

Feedback plc

Rory Shaw, Chairman

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

+44 (0)20 7457 2020

[email protected]

 

About Feedback plcwww.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

Feedback has launched BleepaTM, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on BleepaTM, see www.bleepa.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.  

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rory Shaw

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in consideration of payment of fees

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

5,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

23 April 2020

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lindsay Melvin

2

Reason for the notification

a)

Position/status

Finance Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for Ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in accordance with the Company's EMI Share Option Scheme

 

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

1,500,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

23 April 2020

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mike Hayball

2

Reason for the notification

a)

Position/status

 Director of Feedback Medical Limited (Person Discharging Managerial Responsibilities)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for Ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in consideration of payment of fees

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

2,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

23 April  2020

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Brown

2

Reason for the notification

a)

Position/status

Director of Feedback Medical Limited (Person Discharging Managerial Responsibilities)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for Ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in consideration of payment of fees

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

2,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

23 April 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Mayhew

2

Reason for the notification

a)

Position/status

 Manager at Feedback Medical Limited (Person Discharging Managerial Responsibilities)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for Ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in consideration of payment of fees

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

2,000,,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

6 April 2020

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen McAteer

2

Reason for the notification

a)

Position/status

Manager at Feedback Medical Limited (Person Discharging Managerial Responsibilities)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Options to subscribe for Ordinary Shares of 0.25p each

 

 

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550
 

 

b)

Nature of the transaction

Issue of options to subscribe for Ordinary Shares in consideration of payment of fees

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

Exercise price of 1.2p

 

2,000,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A

 

e)

Date of the transaction

23 April 2020

f)

Place of the transaction

Outside a trading venue

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHPPURUCUPUGMW

Quick facts: Feedback PLC

Price: 0.975

Market: LSE
Market Cap: £10.4 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

'Undoubtedly an exciting time for Texrad' says Feedback plc Chairman

Feedback plc (LON:FDBK) chairman Alastair Riddell caught up with Proactive's Andrew Scott to discuss their latest results and outlook for the company. They’re a leader in medical image processing and analysis with their lead product Texrad - a software instrument for analysing medical...

on 11/17/2016